| Genetics and pathogenesis of diffuse large B-cell lymphoma R Schmitz, GW Wright, DW Huang, CA Johnson, JD Phelan, JQ Wang, ... New England Journal of Medicine 378 (15), 1396-1407, 2018 | 1803 | 2018 |
| A multiprotein supercomplex controlling oncogenic signalling in lymphoma JD Phelan, RM Young, DE Webster, S Roulland, GW Wright, M Kasbekar, ... Nature 560 (7718), 387-391, 2018 | 346 | 2018 |
| High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations BT Mott, RT Eastman, R Guha, KS Sherlach, A Siriwardana, P Shinn, ... Scientific reports 5 (1), 13891, 2015 | 113 | 2015 |
| Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site M Kasbekar, G Fischer, BT Mott, A Yasgar, M Hyvönen, HIM Boshoff, ... Proceedings of the National Academy of Sciences 113 (27), 7503-7508, 2016 | 42 | 2016 |
| Overcoming acquired epigenetic resistance to BTK inhibitors AL Shaffer III, JD Phelan, JQ Wang, DW Huang, GW Wright, M Kasbekar, ... Blood Cancer Discovery 2 (6), 630-647, 2021 | 32 | 2021 |
| Targeted FGFR inhibition results in a durable remission in an FGFR1-driven myeloid neoplasm with eosinophilia M Kasbekar, V Nardi, P Dal Cin, AM Brunner, M Burke, YB Chen, ... Blood Advances 4 (13), 3136-3140, 2020 | 32 | 2020 |
| Hematopoietic stem cells through the ages: A lifetime of adaptation to organismal demands M Kasbekar, CA Mitchell, MA Proven, E Passegué Cell Stem Cell, 2023 | 12 | 2023 |
| Targeting of Fumarate Hydratase from Mycobacterium tuberculosis Using Allosteric Inhibitors with a Dimeric-Binding Mode AJ Whitehouse, MDJ Libardo, M Kasbekar, PD Brear, G Fischer, ... Journal of medicinal chemistry 62 (23), 10586-10604, 2019 | 12 | 2019 |
| Stereoelectronic Effects in Dihapto-Coordinated Complexes of TpW(NO)(PMe3) and Their Manifestation in Diels−Alder Cycloaddition of Arenes RJ Salomon, EC Lis Jr, MU Kasbekar, KC Bassett, WH Myers, CO Trindle, ... Organometallics 28 (16), 4724-4734, 2009 | 10 | 2009 |
| Response to Bruton’s tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagy JD Phelan, S Scheich, J Choi, GW Wright, B Häupl, RM Young, SA Rieke, ... Cancer Cell, 2024 | 2 | 2024 |
| Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy JD Phelan, S Scheich, J Choi, G Wright, B Häupl, RM Young, S Rieke, ... Blood 142, 850, 2023 | 1 | 2023 |
| No cell left behind: Residual ovarian spheroids drive recurrence and are sensitive to the pro-oxidant elesclomol IS Goldlust, K Wilson, L Szabova, X Zhang, L Mathews-Griner, M Vias, ... Cancer Research 76 (14_Supplement), 278-278, 2016 | 1 | 2016 |
| Maternal inflammation regulates fetal emergency myelopoiesis A Collins, JW Swann, MA Proven, CM Patel, CA Mitchell, M Kasbekar, ... Cell, 2024 | | 2024 |
| Maternal IL-10 restricts fetal emergency myelopoiesis A Collins, JW Swann, MA Proven, C Patel, CA Mitchell, M Kasbekar, ... bioRxiv, 2023.09. 13.557548, 2023 | | 2023 |
| Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program M Kasbekar, V Nardi, P Dal Cin, AM Brunner, YB Chen, C Connolly, ... Blood 134, 5371, 2019 | | 2019 |
| Abstract PR13: CRISPRi screening with targeted therapeutics classifies functional long non-coding RNAs in DLBCL DE Webster, JD Phelan, M Kasbekar, AL Shaffer III, LM Staudt Molecular Cancer Therapeutics 16 (10_Supplement), PR13-PR13, 2017 | | 2017 |
| ORGN 586-Formal [4+ 2] cycloadditions to arenes promoted by a tungsten metal fragment to generate [2.2. 2] bicyclooctenones and a bicyclooctadiene RJ Salomon, M Kasbekar, WD Harman ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 236, 2008 | | 2008 |
